This announcement is a separate document:
開拓藥業-B：公告 內幕消息 普克魯胺治療輕中症新冠患者III期臨床試驗中期分析進展
KINTOR PHARMA-B: ANNOUNCEMENT INSIDE INFORMATION INTERIM ANALYSIS FOR PHASE III STUDY OF PROXALUTAMIDE FOR PATIENTS WITH MILD TO MODERATE COVID-19 SYMPTOMS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.